BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 34978539)

  • 21. Association Between Portosystemic Shunts and Increased Complications and Mortality in Patients With Cirrhosis.
    Simón-Talero M; Roccarina D; Martínez J; Lampichler K; Baiges A; Low G; Llop E; Praktiknjo M; Maurer MH; Zipprich A; Triolo M; Vangrinsven G; Garcia-Martinez R; Dam A; Majumdar A; Picón C; Toth D; Darnell A; Abraldes JG; Lopez M; Kukuk G; Krag A; Bañares R; Laleman W; La Mura V; Ripoll C; Berzigotti A; Trebicka J; Calleja JL; Tandon P; Hernandez-Gea V; Reiberger T; Albillos A; Tsochatzis EA; Augustin S; Genescà J;
    Gastroenterology; 2018 May; 154(6):1694-1705.e4. PubMed ID: 29360462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patients with liver cirrhosis show worse survival if decompensation occurs later during course of disease than at diagnosis.
    Nilsson E; Anderson H; Sargenti K; Lindgren S; Prytz H
    Scand J Gastroenterol; 2018 Apr; 53(4):475-481. PubMed ID: 29513096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Total area of spontaneous portosystemic shunts independently predicts hepatic encephalopathy and mortality in liver cirrhosis.
    Praktiknjo M; Simón-Talero M; Römer J; Roccarina D; Martínez J; Lampichler K; Baiges A; Low G; Llop E; Maurer MH; Zipprich A; Triolo M; Maleux G; Fialla AD; Dam C; Vidal-González J; Majumdar A; Picón C; Toth D; Darnell A; Abraldes JG; López M; Jansen C; Chang J; Schierwagen R; Uschner F; Kukuk G; Meyer C; Thomas D; Wolter K; Strassburg CP; Laleman W; La Mura V; Ripoll C; Berzigotti A; Calleja JL; Tandon P; Hernandez-Gea V; Reiberger T; Albillos A; Tsochatzis EA; Krag A; Genescà J; Trebicka J;
    J Hepatol; 2020 Jun; 72(6):1140-1150. PubMed ID: 31954206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessing the Risk of Further Decompensation and Survival in Patients With Cirrhosis With Variceal Bleeding as Their First Decompensation Event.
    Gupta A; Rana R; Agarwal S; Sharma S; Gopi S; Mohta S; Gunjan D; Saraya A
    Am J Gastroenterol; 2023 May; 118(5):833-839. PubMed ID: 36114777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cirrhosis with ascites: Is the presence of hemorrhagic ascites an indicator of poor prognosis?
    Yıldız H; Akdoğan M; Suna N; Öztaş E; Kuzu UB; Bilge Z; Aydınlı O; Taşkıran İ
    Turk J Gastroenterol; 2016 Jul; 27(4):349-53. PubMed ID: 27124284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diabetes Is Associated with Clinical Decompensation Events in Patients with Cirrhosis.
    Liu TL; Trogdon J; Weinberger M; Fried B; Barritt AS
    Dig Dis Sci; 2016 Nov; 61(11):3335-3345. PubMed ID: 27480088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MELD-Lactate Predicts Poor Outcome in Variceal Bleeding in Cirrhosis.
    Horvatits T; Mahmud N; Serper M; Seiz O; Reher D; Drolz A; Sarnast N; Gu W; Erasmus HP; Allo G; Ferstl P; Wittmann S; Piecha F; Groth S; Zeuzem S; Schramm C; Huber S; Rösch T; Lohse AW; Trebicka J; Ogola G; Asrani SK; Kluwe J
    Dig Dis Sci; 2023 Mar; 68(3):1042-1050. PubMed ID: 36376577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recalibrated MELD and hepatic encephalopathy are prognostic factors in cirrhotic patients with acute variceal bleeding.
    Rudler M; Bureau C; Carbonell N; Mathurin P; Saliba F; Mallat A; Massard J; Golmard JL; Bernard-Chabert B; Dib N; Thabut D;
    Liver Int; 2018 Mar; 38(3):469-476. PubMed ID: 29164762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Refit model for end-stage liver disease-Na is not a better predictor of mortality than the Refit model for end-stage liver disease in patients with cirrhosis and ascites.
    Kim JJ; Kim JH; Koo JK; Choi YJ; Ko SY; Choe WH; Kwon SY
    Clin Mol Hepatol; 2014 Mar; 20(1):47-55. PubMed ID: 24757658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical outcomes following DAA therapy in patients with HCV-related cirrhosis depend on disease severity.
    Krassenburg LAP; Maan R; Ramji A; Manns MP; Cornberg M; Wedemeyer H; de Knegt RJ; Hansen BE; Janssen HLA; de Man RA; Feld JJ; van der Meer AJ
    J Hepatol; 2021 May; 74(5):1053-1063. PubMed ID: 33242501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Level of MFAP4 in ascites independently predicts 1-year transplant-free survival in patients with cirrhosis.
    Torp N; Israelsen M; Madsen B; Lutz P; Jansen C; Strassburg C; Mortensen C; Knudsen AW; Sorensen GL; Holmskov U; Schlosser A; Thiele M; Trebicka J; Krag A
    JHEP Rep; 2021 Jun; 3(3):100287. PubMed ID: 34041469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transjugular Intrahepatic Porto-Systemic Shunt in Patients with Liver Cirrhosis and Model for End-Stage Liver Disease ≥15.
    Ascha M; Hanouneh M; S Ascha M; Zein NN; Sands M; Lopez R; Hanouneh IA
    Dig Dis Sci; 2017 Feb; 62(2):534-542. PubMed ID: 27154510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trends in Characteristics, Mortality, and Other Outcomes of Patients With Newly Diagnosed Cirrhosis.
    Orman ES; Roberts A; Ghabril M; Nephew L; Desai AP; Patidar K; Chalasani N
    JAMA Netw Open; 2019 Jun; 2(6):e196412. PubMed ID: 31251379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transjugular intrahepatic portosystemic shunt (TIPS) placement at index portal hypertensive decompensation (anticipant TIPS) in cirrhosis and the role of early intervention in variceal bleeding and ascites.
    Rajesh S; Philips CA; Betgeri SS; George T; Ahamed R; Mohanan M; Augustine P
    Indian J Gastroenterol; 2021 Aug; 40(4):361-372. PubMed ID: 34324168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The incidence and outcome of postoperative hepatic encephalopathy in patients with cirrhosis.
    Saleh ZM; Solano QP; Louissaint J; Jepsen P; Tapper EB
    United European Gastroenterol J; 2021 Jul; 9(6):672-680. PubMed ID: 34102040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bacterial infections adversely influence the risk of decompensation and survival in compensated cirrhosis.
    Villanueva C; Albillos A; Genescà J; Garcia-Pagan JC; Brujats A; Calleja JL; Aracil C; Bañares R; Morillas RM; Poca M; Peñas B; Augustin S; Abraldes JG; Alvarado E; Torres F; Bosch J;
    J Hepatol; 2021 Sep; 75(3):589-599. PubMed ID: 33905794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is Anesthesia Technique Associated With a Higher Risk of Mortality or Complications Within 90 Days of Surgery for Geriatric Patients With Hip Fractures?
    Desai V; Chan PH; Prentice HA; Zohman GL; Diekmann GR; Maletis GB; Fasig BH; Diaz D; Chung E; Qiu C
    Clin Orthop Relat Res; 2018 Jun; 476(6):1178-1188. PubMed ID: 29601378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of risk scoring systems for cirrhotic patients with variceal bleeding.
    Tantai XX; Liu N; Yang LB; Wei ZC; Xiao CL; Song YH; Wang JH
    World J Gastroenterol; 2019 Dec; 25(45):6668-6680. PubMed ID: 31832005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. No Differences Between White and Non-White Patients in Terms of Care Quality Metrics, Complications, and Death After Hip Fracture Surgery When Standardized Care Pathways Are Used.
    Parola R; Neal WH; Konda SR; Ganta A; Egol KA
    Clin Orthop Relat Res; 2023 Feb; 481(2):324-335. PubMed ID: 35238810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The MELD score in advanced liver disease: association with clinical portal hypertension and mortality.
    Saab S; Landaverde C; Ibrahim AB; Durazo F; Han S; Yersiz H; Farmer DG; Ghobrial RM; Goldstein LI; Tong MJ; Busuttil RW
    Exp Clin Transplant; 2006 Jun; 4(1):395-9. PubMed ID: 16827633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.